Top

Osteoporosis International

Published in:

01-04-2012 | Original Article

Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)

Authors: P. Vestergaard, P. Hermann, J.-E. B. Jensen, P. Eiken, L. Mosekilde

Published in: Osteoporosis International | Issue 4/2012

Abstract

Summary

Pain medication has been associated with fractures. We found higher weight in paracetamol and non-steroidal anti-inflammatory drugs (NSAID) users and lower vitamin D levels in opioid and acetylsalicylic acid users. None of the pain medications influenced bone mineral density or loss. NSAID were associated with an increased fracture risk.

Introduction

To study the effects of use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID), acetylsalicylic acid (ASA), and opioids on bone mineral density (BMD) and risk of fractures.

Methods

Two-thousand sixteen perimenopausal women followed for 10 years as part of a partly randomised comprehensive cohort study on hormone therapy (HT). BMD was measured at baseline and after 10 years by DXA (Hologic).

Results

Paracetamol users were heavier (70.4 ± 13.4 vs. 67.7 ± 11.9 kg, 2p < 0.01) than non-users. NSAID users were heavier (71.6 ± 15.6 vs. 67.8 ± 11.9 kg, 2p = 0.04) than non-users. ASA users had lower 25-hydroxy-vitamin D (25OHD) levels (21.9 ± 9.3 vs. 25.3 ± 12.4 ng/ml, 2p < 0.01) than non-users. Opioid users had lower 25OHD (21.4 ± 8.4 vs. 25.2 ± 12.3 ng/ml) and lower intake of vitamin D (2.2 ± 1.1 vs. 3.1 ± 3.0 μg/day, 2p < 0.01) than non-users. Despite these differences, no baseline differences were present in spine, hip, forearm or whole body BMD. Over 10 years, no differences were present in BMD alterations except a small trend towards a higher BMD gain in the spine in users of paracetamol, NSAID, ASA, and opioids compared to non-exposed. After adjustment, NSAID exposed sustained more fractures (HR = 1.44, 95% CI 1.07–1.93) than non-users. For users of paracetamol and opioids, a non-significant trend towards more fractures was present after adjustment. For ASA users, no excess risk of fractures was present.

Conclusion

Significant differences exist between subjects exposed to pain medications and non-users. Despite an absence of an effect over time on BMD, users of NSAID experienced more fractures than expected. The reasons for this have to be explored in further studies.

Kinjo M, Setoguchi S, Schneeweiss S, Solomon D (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118:1414.e7–1414.e12CrossRef

Daniell H (2002) Hypogonadism in men consuming sustained-action oral opioids. J Pain 3:377–384CrossRefPubMed

Hallinan R, Byrne A, Agho K, McMahon CG, Tynan P, Attia J (2009) Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 32:131–139CrossRefPubMed

Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of morphine and opiates. J Intern Med 260:76–87CrossRefPubMed

Bauer D, Orwoll E, Fox K, Vogt T, Lane N, Hochberg M, Stone K, Nevitt M (1996) Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:29–35CrossRefPubMed

Carbone L, Tylavsky F, Cauley J, Harris T, Lang T, Bauer D, Barrow K, Kritchevsky S (2003) Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res 18:1795–1802CrossRefPubMed

Raisz L (1995) Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 125:2024S–2027SPubMed

Raisz L (1999) Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 7:419–421CrossRefPubMed

Raisz L (2001) Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med 110(Suppl 3A):43S–45SCrossRefPubMed

10.

van Staa T, Leufkens H, Cooper C (2000) Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone 27:563–568CrossRefPubMed

11.

Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 79:84–94CrossRefPubMed

12.

Aisen P, Schafer K, Grundman M, Pfeiffer E, Sano M, Davis K, Farlow M, Jin S, Thomas R, Thal L (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289:2819–2826CrossRefPubMed

13.

Bannwarth B, Treves R, Euller-Ziegler L, Rolland D, Ravaud P, Dougados M (2003) Adverse events associated with rofecoxib therapy: results of a large study in community-derived osteoarthritic patients. Drug Saf 26:49–54CrossRefPubMed

14.

Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S, Vrijens F, Malbecq W, Lines C, Visser W, Reines S, Yuen E (2004) Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. Neurology 62:1552–1557PubMed

15.

Walker PC, Alrawi A, Mitchell JF, Regal RE, Khanderia U (2005) Medication use as a risk factor for falls among hospitalized elderly patients. Am J Health Syst Pharm 62:2495–2499CrossRefPubMed

16.

Barden J, Edwards J, Moore R, McQuay H (2004) Single dose oral diclofenac for postoperative pain. Cochrane Database Syst Rev (2):CD004768.

17.

Hegeman J, van den Bemt BJF, Duysens J, van Limbeek J (2009) NSAIDs and the risk of accidental falls in the elderly: a systematic review. Drug Saf 32:489–498CrossRefPubMed

18.

Hegeman J, Nienhuis B, van den Bemt B, Weerdesteyn V, van Limbeek J, Duysens J (2010) The effect of a non-steroidal anti-inflammatory drug on two important predictors for accidental falls: postural balance and manual reaction time. A randomized, controlled pilot study. Hum Mov Sci 30:384–395CrossRefPubMed

19.

García-Martínez O, Díaz-Rodríguez L, Rodríguez-Pérez L, De Luna-Bertos E, Botella CR, Ruiz CC (2010) Effect of acetaminophen, ibuprofen and methylprednisolone on different parameters of human osteoblast-like cells. Arch Oral Biol 56:317–323CrossRefPubMed

20.

Díaz-Rodríguez L, García-Martínez O, Arroyo-Morales M, Rubio-Ruiz B, Ruiz C (2010) Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63. Acta Pharmacol Sin 31:1495–1499CrossRefPubMed

21.

Mosekilde L, Hermann A, Beck-Nielsen H, Charles P, Nielsen S, Sørensen O (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2016 normal perimenopausal women. Maturitas 31:207–219CrossRefPubMed

22.

Mosekilde L, Beck-Nielsen H, Sørensen O, Nielsen S, Charles P, Vestergaard P, Hermann A, Gram J, Hansen T, Abrahamsen B, Ebbesen E, Stilgren L, Jensen L, Brot C, Hansen B, Tofteng C, Eiken P, Kolthoff N (2000) Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women—results of the Danish Osteoporosis Prevention Study. Maturitas 36:181–193CrossRefPubMed

23.

Brixen K, Nielsen HK, Eriksen EF, Charles P, Mosekilde L (1989) Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int 44:93–98CrossRefPubMed

24.

Lund B, Sorensen O (1979) Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 39:23–30CrossRefPubMed

25.

Abrahamsen B, Gram J, Hansen T, Beck-Nielsen H (1995) Cross-calibration of QDR-2000 and QDR-1000 dual energy X-ray densitometers for bone mineral and soft tissue measurements. Bone 16:385–391CrossRefPubMed

26.

De Laet C, Kanis J, Oden A, Johanson H, Johnell O, Delmas P, Eisman J, Kroger H, Fujiwara S, Garnero P, McCloskey E, Mellstrom D, Melton LJ III, Meunier P, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis Int 16:1330–1338CrossRef

27.

Lovell S, Taira T, Rodriguez E, Wackett A, Gulla J, Singer A (2004) Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial. Acad Emerg Med 11:1278–1282PubMed

28.

Vestergaard P (2008) Pain-relief medication and risk of fractures. Curr Drug Saf 3:199–203CrossRefPubMed

29.

Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259CrossRefPubMed

30.

Dimmen S, Nordsletten L, Engebretsen L, Steen H, Madsen JE (2008) Negative effect of parecoxib on bone mineral during fracture healing in rats. Acta Orthop 79:438–444CrossRefPubMed

31.

Dimmen S, Nordsletten L, Madsen JE (2009) Parecoxib and indomethacin delay early fracture healing: a study in rats. Clin Orthop Relat Res 467:1992–1999CrossRefPubMed

32.

Bischoff H, Stahelin H, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, Tyndall A, Theiler R (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80:54–58CrossRefPubMed

33.

Bischoff H, St. helin H, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew R, Conzelmann M (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343–351CrossRefPubMed

Title: Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)
Authors: P. Vestergaard
P. Hermann
J.-E. B. Jensen
P. Eiken
L. Mosekilde
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 4/2012
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-011-1692-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)

Abstract

Summary

Introduction

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2012

Exercise and fractures in postmenopausal women: 12-year results of the Erlangen Fitness and Osteoporosis Prevention Study (EFOPS)

Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage

Non-elite gymnastics participation is associated with greater bone strength, muscle size, and function in pre- and early pubertal girls

Erratum to: Ethnic differences in composite indices of femoral neck strength

Fracture risk assessment in patients with chronic kidney disease

Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level